Affiliation:
1. Department of Family Medicine and Primary Care The University of Hong Kong Hong Kong SAR China
2. Centre for Safe Medication Practice and Research Department of Pharmacology and Pharmacy The University of Hong Kong Hong Kong SAR China
3. Laboratory of Data Discovery for Health (D24H) Hong Kong Science and Technology Park Sha Tin Hong Kong, China
4. Department of Family Medicine and Primary Care The University of Hong Kong Shenzhen Hospital Shenzhen China
5. Medical Research Council (MRC) Biostatistics Unit University of Cambridge Cambridge United Kingdom
6. Research Department of Practice and Policy School of Pharmacy University College London London United Kingdom
Abstract
Background
The detrimental effects of increased variability in systolic blood pressure (SBP) on cardiovascular disease (CVD) and mortality risk in patients with diabetes mellitus remains unclear. This study evaluated age‐specific association of usual SBP visit‐to‐visit variability with CVD and mortality in patients with type 2 diabetes mellitus.
Methods and Results
A retrospective cohort study investigated 155 982 patients with diabetes mellitus aged 45 to 84 years without CVD at baseline (2008–2010). Usual SBP variability was estimated using SBP SD obtained from a mixed‐effects model. Age‐specific associations (45–54, 55–64, 65–74, 75–84 years) between usual SBP variability, CVD, and mortality risk were assessed by Cox regression adjusted for patient characteristics. After a median follow‐up of 9.7 years, 49 816 events (including 34 039 CVD events and 29 211 mortalities) were identified. Elevated SBP variability was independently, positively, and log‐linearly associated with higher CVD and mortality risk among all age groups, with no evidence of any threshold effects. The excess CVD and mortality risk per 5 mm Hg increase in SBP variability within the 45 to 54 age group is >3 times higher than the 70 to 79 age group (hazard ratio, 1.66; 95% CI, 1.49–1.85 versus hazard ratio, 1.19; 95% CI, 1.15–1.23). The significant associations remained consistent among all subgroups. Patients with younger age had a higher association of SBP variability with event outcomes.
Conclusions
The findings suggest that SBP visit‐to‐visit variability was strongly associated with CVD and mortality with no evidence of a threshold effect in a population with diabetes mellitus. As well as controlling overall blood pressure levels, SBP visit‐to‐visit variability should be monitored and evaluated in routine practice, in particular for younger patients.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Reference45 articles.
1. International Diabetes Federation . IDF Diabetes Atlas Eighth Edition 2017. Brussels: International Diabetes Federation; 2017.
2. Complications of Diabetes 2017;Papatheodorou K;J Diabetes Res,2018
3. International Diabetes Federation
Diabetes and cardiovascular disease. 2016.
4. Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality
5. Association of Blood Pressure Lowering With Mortality and Cardiovascular Disease Across Blood Pressure Levels
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献